NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE

Product NDC
60219-2084
11-digit product format
602192084
Labeler code
60219
Product ID
60219-2084_22c9a9e5-2701-4f12-90a5-97ebf87c62b8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
neomycin sulfate, polymyxin b sulfate and hydrocortisone
Dosage form
SUSPENSION/ DROPS
Route
AURICULAR (OTIC)
Labeler
Amneal Pharmaceuticals NY LLC
Application
ANDA217735
Marketing category
ANDA
Marketing start
2025-09-30
Substance
HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Active strength
10; 3.5; 10000 mg/mL; mg/mL; [USP'U]/mL
Pharmacologic classes
Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
WI4X0X7BPJHYDROCORTISONE50-23-7HYDROCORTISONE
057Y626693NEOMYCIN SULFATE1405-10-3NEOMYCIN SULFATE
19371312D4POLYMYXIN B SULFATE1405-20-5POLYMYXIN B SULFATE

Packages

Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
60219-2084-6602192084061 BOTTLE, PLASTIC in 1 CARTON (60219-2084-6) / 10 mL in 1 BOTTLE, PLASTIC2025-09-30NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension, USPAmneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited2025-10-06HUMAN PRESCRIPTION DRUG LABEL4